Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
The American Journal of Managed Care
|
February 6, 2014
Multiple sclerosis update
Clyde E Markowitz
The American Journal of Managed Care
|
September 30, 2010
The current landscape and unmet needs in multiple sclerosis
Clyde E Markowitz
Neurology
|
June 19, 2007
Interferon-beta: mechanism of action and dosing issues
Clyde E Markowitz
The Journal of Clinical Psychiatry
|
March 6, 2015
Switching therapies in MS: what are the options?
Clyde E Markowitz
The Journal of Clinical Psychiatry
|
April 2, 2015
Identifying and addressing unmet therapeutic needs in MS
Clyde E Markowitz
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
May 9, 2025
Beyond relapses: How BTK inhibitors are shaping the future of progressive MS treatment
Laura R Naydovich, Jennifer L Orthmann-Murphy, Clyde E Markowitz
Neurology
|
October 15, 2003
The "double panda sign" in Wilson's disease
Dina A Jacobs, Clyde E Markowitz, David S Liebeskind, et al.
Acta Radiologica (Stockholm, Sweden : 1987)
|
April 9, 2015
Limbic pathway lesions in patients with multiple sclerosis
Neslin Sahin, Roger Selouan, Clyde E Markowitz, et al.
Expert Review of Neurotherapeutics
|
December 17, 2010
Fingolimod for the treatment of relapsing multiple sclerosis
Douglas R Jeffery, Clyde E Markowitz, Anthony T Reder, et al.
Neuroimage
|
June 26, 2013
Direct visualization of short transverse relaxation time component (ViSTa)
Se-Hong Oh, Michel Bilello, Matthew Schindler, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
The American Journal of Managed Care
|
February 6, 2014
Multiple sclerosis update
Clyde E Markowitz
The American Journal of Managed Care
|
September 30, 2010
The current landscape and unmet needs in multiple sclerosis
Clyde E Markowitz
Neurology
|
June 19, 2007
Interferon-beta: mechanism of action and dosing issues
Clyde E Markowitz
The Journal of Clinical Psychiatry
|
March 6, 2015
Switching therapies in MS: what are the options?
Clyde E Markowitz
The Journal of Clinical Psychiatry
|
April 2, 2015
Identifying and addressing unmet therapeutic needs in MS
Clyde E Markowitz
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
May 9, 2025
Beyond relapses: How BTK inhibitors are shaping the future of progressive MS treatment
Laura R Naydovich, Jennifer L Orthmann-Murphy, Clyde E Markowitz
Neurology
|
October 15, 2003
The "double panda sign" in Wilson's disease
Dina A Jacobs, Clyde E Markowitz, David S Liebeskind, et al.
Acta Radiologica (Stockholm, Sweden : 1987)
|
April 9, 2015
Limbic pathway lesions in patients with multiple sclerosis
Neslin Sahin, Roger Selouan, Clyde E Markowitz, et al.
Expert Review of Neurotherapeutics
|
December 17, 2010
Fingolimod for the treatment of relapsing multiple sclerosis
Douglas R Jeffery, Clyde E Markowitz, Anthony T Reder, et al.
Neuroimage
|
June 26, 2013
Direct visualization of short transverse relaxation time component (ViSTa)
Se-Hong Oh, Michel Bilello, Matthew Schindler, et al.
Page
of 4